Horizon Therapeutics Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
PTLAPortola Pharmaceuticals, Inc. -0.50%17.866.5%$164.24m
HZNPHorizon Therapeutics Plc -1.70%49.876.5%$143.87m
CTLTCatalent, Inc. -0.41%77.412.3%$138.46m
MYOKMyoKardia, Inc. 2.32%104.661.8%$133.37m
BHCBausch Health Cos., Inc. 5.84%19.560.0%$126.50m
VRXValeant Pharmaceuticals International, Inc. 6.09%19.6114.1%$115.39m
UTHRUnited Therapeutics Corp. 0.98%119.1114.3%$75.92m
ICPTIntercept Pharmaceuticals, Inc. 2.06%73.7516.8%$60.90m
JAZZJazz Pharmaceuticals Plc 0.15%119.502.4%$60.73m
GWPHGW Pharmaceuticals Plc 2.37%125.666.2%$57.31m
AMRNAmarin Corp. Plc -1.58%6.751.6%$57.06m
ARGXargenx SE 1.55%222.700.0%$53.72m
AXSMAxsome Therapeutics, Inc. -0.49%76.601.9%$50.42m
PRGOPerrigo Co. Plc 1.64%55.676.8%$46.50m
ICLRICON plc 1.39%170.794.3%$45.06m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.